J Vet Sci.  2019 Mar;20(2):e16. 10.4142/jvs.2019.20.e16.

Preparation, characterization, and in vivo evaluation of a polymorphic form of valnemulin hydrogen tartrate

Affiliations
  • 1Safety Assessment Department, China Institute of Veterinary Drug Control, Beijing 100081, China. flyingletter20088@163.com

Abstract

We prepared a polymorphic form of valnemulin hydrogen tartrate (Form I) to overcome the instability and irritating odor of valnemulin hydrochloride that affect its use in the production and application of veterinary drugs. The physicochemical properties of Form I were characterized by scanning electron microscopy, X-ray powder diffraction, infrared spectroscopy, differential scanning calorimetry, and thermogravimetric analysis. The results showed the crystal structure and thermal properties of Form I were very different from those of a commercially available form of valnemulin hydrogen tartrate (Form II). Form I and Form II were more stable than valnemulin hydrochloride after storage under irradiation and high humidity conditions, respectively. The solubility of Form I was 2.6 times that of Form II, and Form I was selected for use in pharmaceutical kinetics experiments in vivo. Compared to valnemulin hydrochloride, after oral administration at a dose of 10 mg/kg in pigs, Form I had similar pharmaceutical kinetic behavior but a slightly higher area under the concentration-time curve from time zero to the last measurable concentration. Consequently, Form I should be suitable for the development of simple formulations and be effective in the clinical application of veterinary drugs.

Keyword

Pharmacokinetics; polymorphism; solubility; valnemulin; pigs

MeSH Terms

Administration, Oral
Calorimetry, Differential Scanning
Humidity
Hydrogen*
Kinetics
Microscopy, Electron, Scanning
Odors
Pharmacokinetics
Powder Diffraction
Solubility
Spectrum Analysis
Swine
Veterinary Drugs
Hydrogen
Veterinary Drugs
Full Text Links
  • JVS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr